On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayAug 21, 2020 1:10 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded Key Patent for Critical Addition to Instruments, Consumables Product Line

Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’ IP ownership to include 25 issued patents protecting its unique pressure-cycling technology (“PCT”) systems. The newly patented PCT MicroPestle (“MP”) is a critical addition to the company’s instruments and consumables product line. A recent article discussing this reads, “The PCT MP is the company’s most important and popular consumable to date, having a unique construction that seals and protects the sample while flexing to transfer immense pressures…

Continue Reading

FridayAug 14, 2020 8:30 am

Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device

Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market, which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important and popular consumable to date PBI has seen revenue…

Continue Reading

WednesdayAug 12, 2020 12:24 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Achieves Critical Milestone Through Award of Key Patent

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled "Sample Preparation Devices and Methods." According to the update, the new patent (U.S. 10,710,082) brings the company's intellectual property ("IP") estate up to a total of 25 issued patents. "We have many customers worldwide who routinely use our ‘PCT’ Micro-Pestle consumable in their research studies. These include Professor Phil Robinson and his team at the Children's Medical Research Institute in Australia (processing…

Continue Reading

WednesdayJul 08, 2020 9:42 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q1 2020 Results and Provide Business Update

Pressure BioSciences (OTCQB: PBIO) on Tuesday announced that it will host a teleconference to discuss its first quarter 2020 financial results and to provide a business update, including the Company’s progress made in the development of its Ultra Shear Technology(TM) ("UST(TM)) Platform and in the pending merger of PBI, Cannaworx, and SkinScience Labs. The call is scheduled to take place at 4:30 p.m. Eastern Time on July 8, 2020. Interested parties may join the conference by dialing (844) 602-0380 (North America) or (862) 298-0970 (International) and entering verbal passcode: PBI First Quarter 2020 Financial Call & Business Update. For those…

Continue Reading

TuesdayJun 30, 2020 11:23 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) and Leica Microsystems Collaborate to Offer Innovative Combined Workflow Expected to Accelerate Cancer R&D

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. "The generation of reliable and reproducible data from biopsy samples is difficult, as it requires…

Continue Reading

FridayJun 19, 2020 1:58 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Pending Acquisition Target Secures $3.5M Initial Hand Sanitizer Order

Pressure BioSciences (OTCQB: PBIO), recently announced that SkinScience Labs (“SSL”) has secured an initial $3.5 million order for its premium FDA-registered dermatological hand sanitizer product (http://ibn.fm/KE7x5). A leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions, Pressure BioSciences will acquire SSL through its planned acquisition of Cannaworx, which is expected to close by June 30, 2020. A recent article discussing the company further reads, “The $3.5 million order announced on June 11 is merely the initial order for a four-month supply of the premium, dermatological, hand-sanitizer product. Mr. Morrison expects future orders and…

Continue Reading

ThursdayJun 18, 2020 11:01 am

Pressure BioSciences, Inc. (PBIO) Enters Multi-Billion Dollar Hand Sanitizer Market Following $3.5M Initial Order for Pending Acquisition Partner SkinScience Labs’ Premium New Product

Merger of Pressure BioSciences, SkinScience Labs and Cannaworx, Inc. is expected to close by June 30, 2020 SkinScience Labs is the parent company of the award-winning Dr. Denese skin care and anti-aging product lines, a top QVC seller generating sales of over $500M since 2003 The $3.5M order is for an initial four-month supply of SkinScience Labs’ (SSL)premium grade hand sanitizer Hand sanitizer market is growing exponentially; it is expected to reach $5.5 billion by 2024 SkinScience Labs and Cannaworx product lines will leverage Pressure BioSciences’ proprietary Ultra Shear Technology (UST) for preparing high quality nanoemulsions to drive product quality…

Continue Reading

ThursdayJun 11, 2020 11:13 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Merger Partner, SkinScience Labs, Secures Initial $3.3M Order for Premium Hand Sanitizer Product

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its merger partner SkinScience Labs, Inc. has received an initial $3.5 million order for its newly developed, premium, dermatological hand sanitizer product.  An industry leader in scientific skin care breakthrough technologies, Adrienne Denese, M.D., Ph.D. (Cornell, Harvard) is the founder of the award-winning Dr. Denese SkinScience® product lines. "Our goal has always been to develop and supply the highest quality of personal care products…

Continue Reading

ThursdayJun 04, 2020 11:43 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Initial Manufacturing Run of Revolutionary BaroShear(TM) K45 Processing System Completely Sold Out

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company's initial manufacturing run of its revolutionary BaroShear(TM) K45 processing system. The BaroShear K45, based on the Company's proprietary Ultra Shear Technology(TM) (UST(TM)) platform, is a unique and powerful nanoemulsification system designed to resolve one of today’s most critical problems facing the global hemp-derived cannabinoid industry: how to…

Continue Reading

ThursdayMay 28, 2020 12:51 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Partner Cannaworx to Launch FDA Registered, Hemp-Containing Supplements with Immune Booster Claim

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its pending merger partner Cannaworx, Inc. will be launching its patented and proprietary immune booster supplement by mid-July 2020. According to the update, the company believes that post-launch, this product could be one of the very few, and perhaps the only, OTC (over the counter), FDA registered, hemp-containing supplements with an immune booster claim. “To further enhance the immune boosting effect, we added hemp…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered